ArticleBMC pulmonary medicine2026
Variability of the prognostic nutritional index within 3 months after curative resection for non-small cell lung cancer and 2-year recurrence-free survival.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly recurrence after curative resection remains common in non-small cell lung cancer (NSCLC). We evaluated whether early postoperative trajectories of the prognostic nutritional index (PNI) improve risk stratification.
methodsIn a single-center prospective cohort of patients undergoing R0 resection for stage I-III NSCLC (2021-2025), 119 were enrolled; 94 who were alive and recurrence-free at 3 months with complete PNI data formed the landmark cohort. PNI was measured preoperatively and during the first 3 postoperative months and calculated as 10 × serum albumin (g/dL) + 0.005 × total lymphocyte count (/mm
resultsAmong 94 patients, 51 (54.3%) showed recovered PNI and 43 (45.7%) non-recovered PNI. During follow-up, 27 RFS events occurred, with higher event rates in the non-recovered group (41.9% vs. 17.6%; 2-year RFS 59.2% vs. 82.3%). Non-recovered PNI was independently associated with worse RFS (adjusted hazard ratio 2.3) and improved a clinical model C-index from 0.66 to 0.73. Sensitivity analyses using alternative cutoffs, continuous PNI change, complication adjustment, treatment-timing exclusions, and conservative Cox models were directionally consistent.
conclusionsFailure to recover PNI within 3 months may identify patients at higher risk of recurrence after curative NSCLC resection. Multicenter validation is required before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.